UNSPSC 51281659: Neomycin sulfate

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 057Y626693. European Medicines Agency schedules Neomycin sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03409MIG. Neomycin sulfate generally arises in the molecular formula C23H48N6O17S. The term 'neomycin sulfate' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule neomycin sulfate under HS 29419000 and SITC 54139.

Neomycin sulfate bears US NLM identifiers UMLS ID C0027607 and NCI Concept Code C66227. SMILES: As of Q4 2014, NEOMYCIN SULFATE remains US FDA's Preferred Term for this commodity.

UNSPSC 51281659 Neomycin sulfate is a Commodity code for a specific antibiotic pharmaceutical product, but the recent state and local opportunities posted under this code do not reflect procurement of neomycin sulfate itself. Instead, the tagged solicitations involve other pharmaceutical products — Doxycycline Hyclate and Ciprofloxacin Hydrochloride in one case, and Naloxone and drug deactivation systems in another. State and local health departments and county health agencies are the issuing bodies, acquiring antibiotics and emergency medical supplies through piggyback agreements, cooperative purchasing consortia such as MMCAP Infuse, and competitive sealed bids. The work involves pharmaceutical warehouse distribution, supplier selection based on lowest responsive bid, and contract management with multi-year terms and renewal options.

Recent activity includes the Illinois Department of Public Health's piggyback pharmaceutical warehouse order through MMCAP Infuse Chartwell Rx LLC (Solicitation 26482DPHPREPDB53392, posted August 28, 2026, award amount $2,999,999.11 over three years including renewal periods), and Seminole County, Florida's IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually (IFB 60459723LAS, posted June 30, 2026, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford). The code shows recent activity in Florida and Illinois, though the specific pharmaceutical products tagged do not align with neomycin sulfate procurement, suggesting either a cataloging mismatch in the state and local database or that neomycin sulfate activity is being captured under a different code. Vendors pursuing this category should confirm whether procurement demand actually exists for neomycin sulfate itself or whether the code is being used inconsistently to tag broader pharmaceutical acquisitions.